[Pharmacovigilance update]

Rev Med Suisse. 2013 Jan 9;9(368):72-5.
[Article in French]

Abstract

Main pharmacovigilance updates in 2012 are reviewed here. Dabigatran: elderly patients with renal failure are at higher risk of bleeding. Dual renin-angiotensin-aldosterone system blockade comprising aliskiren is harmful. Incretins: low risk of acute pancreatitis. Interaction between fusidic acid and statins: many reports of rhabdomyolysis. Interactions between boceprevir/telaprevir and antiretroviral therapies: complex, but manageable. Citalopram, ondansetron: maximum recommended doses are reduced. Atomoxetine: significant increase in blood pressure and heart rate in a fraction of exposed patients. Agomelatine: elevated liver enzymes are common. Fingolimod: bradycardia and heart blocks after first dose - stronger safety recommendations regarding use in patients with heart conditions and strengthened cardiovascular monitoring.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adrenergic Uptake Inhibitors / adverse effects
  • Adrenergic Uptake Inhibitors / therapeutic use
  • Age Factors
  • Aged
  • Amides / adverse effects
  • Amides / therapeutic use
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use
  • Atomoxetine Hydrochloride
  • Benzimidazoles / adverse effects
  • Benzimidazoles / therapeutic use
  • Cardiovascular Diseases / chemically induced
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / etiology
  • Dabigatran
  • Drug-Related Side Effects and Adverse Reactions / epidemiology
  • Drug-Related Side Effects and Adverse Reactions / etiology
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use
  • Fumarates / adverse effects
  • Fumarates / therapeutic use
  • Hemorrhage / chemically induced
  • Hemorrhage / epidemiology
  • Humans
  • Pharmacovigilance*
  • Propylamines / adverse effects
  • Propylamines / therapeutic use
  • beta-Alanine / adverse effects
  • beta-Alanine / analogs & derivatives
  • beta-Alanine / therapeutic use

Substances

  • Adrenergic Uptake Inhibitors
  • Amides
  • Antihypertensive Agents
  • Benzimidazoles
  • Fibrinolytic Agents
  • Fumarates
  • Propylamines
  • beta-Alanine
  • aliskiren
  • Atomoxetine Hydrochloride
  • Dabigatran